LONDON, Feb. 13, 2025 /PRNewswire/ -- Precision Cardiovascular (PCV), an innovator in next-generation cardiac health solutions, today announced the appointment…
Original research article published by Frontiers, a top peer-reviewed scientific journal WASHINGTON, Feb. 13, 2025 /PRNewswire/ -- Otolith Labs, a…
Nabla's co-development approach with clinicians informs and drives advances to existing dictation capabilities Voice-to-text Nabla Dictation works together with the…
Augustine Therapeutics appoints Gerhard Koenigas Chief Executive Officer as Company Prepares to Enter the Clinic Industry veteran Gerhard Koenig, PhD,…
RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4%PEAK YEAR SALES TARGETS RAISED FOR…
– Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia…
Vancouver, British Columbia--(Newsfile Corp. - February 13, 2025) - Restart Life Science Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD)…
Vancouver, British Columbia--(Newsfile Corp. - February 13, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF)…
– ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are…
--Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint…